Cabazitaxel is a new drug gives guarantee for extending the lives of men with prostate cancer who have run out of cure options. In a large learn, men given the experimental drug, called cabazitaxel, lived an average of just over 15 months, while those set standard chemotherapy lived an average of almost 13 months.Living an added 2 to 3 months might not sound like much, but all the men had prostate cancer that had spread all over the body despite standard treatment, says study head Oliver Sartor, MD, a cancer investigator in New Orleans.
"These men truly don't have other alternatives," Sartor tells WebMD."They are only probable to live about a year. Cabazitaxel more than increased the number of men that lived minimum of 2years."
You have read this article Health
with the title New Drug Fights against Advanced Prostate Cancer. You can bookmark this page URL http://roxpolitix.blogspot.com/2010/03/new-drug-fights-against-advanced.html. Thanks!
No comment for "New Drug Fights against Advanced Prostate Cancer"
Post a Comment